Meissner Corporation, a leading manufacturer of advanced microfiltration and single-use systems for production of pharmaceutical drugs, biologics, and cell and gene therapies, will invest nearly $250 million in a new manufacturing facility in Athens, Georgia. The project is expected to create over 1,700 new jobs over the next eight years. Meissner’s new facility will include state-of-the-art cleanroom facilities and laboratories, as well as R&D, and office spaces. Meissner expects to begin operations in early 2026 and will be hiring for a broad range of roles. Interested parties can visit the employment listings on www.meissner.com. The Athens, GA location provides direct access to work with schools such as the University of Georgia, Georgia Institute of Technology, and Athens Technical College for internship and collaboration opportunities through relevant programs of study. The project was supported by the Georgia Department of Economic Development, Invest Athens, Georgia Power, and Georgia Quick Start.
